Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Borensztajn, L. Cong, B. Crestani, O. Christophe, A. Spek (Paris, Le Kremlin-Bicêtre, France; Amsterdam, Netherlands). LATE-BREAKING ABSTRACT: Coagulation factor IX deficiency does not afford protection from pulmonary fibrosis in the experimental murine bleomycin model. Eur Respir J 2012; 40: Suppl. 56, 3670

Member's Comments

No comment yet.

Related content which might interest you: Inhalation of activated recombinant factor VII to treat pulmonary hemorrhage in a patient with cystic fibrosis Source: Annual Congress 2011 - Acute respiratory failure Year: 2011 Erythropoietin (EPO) inhibits the bleomycin (BLM)-induced pulmonary fibrosis in rats Source: Annual Congress 2010 - Emerging mechanisms in lung injury Year: 2010 Electroporation mediated gene transfer of hepatocyte growth factor reduces bleomycin induced pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 729s Year: 2005 The effect of tenascin-c deficiency on TGF-β-mediated fibrosis and alveolar inflammation in a murine model of ARDS Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation Year: 2009 The attenuating effect of erythropoietin (EPO) on the expression of myeloperoxidase (MPO) in bleomycin-induced pulmonary fibrosis in rats Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Collagen V activation and matrix extracellular remodeling mediated pulmonary fibrosis in experimental models of bleomycin and 3-5-di-tert-4-hidroxitoluene Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 A transient receptor potential melastin-2 deficiency significantly worsens the fibrotic response to bleomycin in mice Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Antithrombin plus alpha–1 protease inhibitor does not affect pulmonary inflammation and coagulation in a ‘double-hit’ lung injury model Source: International Congress 2018 – Preclinical and clinical studies of critical illness Year: 2018 LATE-BREAKING ABSTRACT: KCa3.1 ion channel-blockade reduces pulmonary fibrotic responses via the inhibition of fibroblast proliferation Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016 Attenuation of bleomycin-induced pulmonary fibrosis by direct thrombin inhibition is accompanied by a reduction in connective tissue growth factor mRNA levels Source: Eur Respir J 2001; 18: Suppl. 33, 199s Year: 2001 The effects of erdosteine and N-acetylcysteine treatment following lung injury on the regulation of apoptosis of capillary endothelial cells in the model of experimental pulmonary fibrosis induced by bleomycin Source: Annual Congress 2008 - Airway cell biology and immunology Year: 2008 LATE-BREAKING ABSTRACT: Aggravation of bleomycin-induced pulmonary fibrosis in senescence-accelerated mouse Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV Year: 2012 Erythropoietin (EPO) attenuates the immunohistochemical expression of tumor growth factor-ß (TGF-ß) in bleomycin (BLM)-induced pulmonary fibrosis (PF) in rats Source: International Congress 2018 – Pulmonary fibrosis: from models to patients Year: 2018 Coagulation factor XII regulates inflammatory responses in human lungs Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury Year: 2017 Regulation, cell-specific expression and metabolism of factor VII activating protease (FSAP) in lungs from patients with acute respiratory distress syndrome (ARDS) and idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2006; 28: Suppl. 50, 823s Year: 2006 Role of Bcl-xL in hepatocyte growth factor elicited epithelial protection in idiopathic lung fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis Year: 2013 Angiotensin II antagonism fails to ameliorate bleomycin-induced pulmonary fibrosis in mice Source: Eur Respir J 2005; 25: 708-714 Year: 2005 Overexpression of hypoxia-inducible factor (HIF)-1α in ischemia/reperfusion injury developed in a lung transplantation model Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 LATE-BREAKING ABSTRACT: Amelioration of hyperoxia-induced lung injury in newborn mice using a sphingolipid-based intervention Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond Year: 2012